0002141066-26-000001.txt : 20260717 0002141066-26-000001.hdr.sgml : 20260717 20260717142042 ACCESSION NUMBER: 0002141066-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260717 DATE AS OF CHANGE: 20260717 EFFECTIVENESS DATE: 20260717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVSF - Alloy Therapeutics 2026, LLC CENTRAL INDEX KEY: 0002141066 ORGANIZATION NAME: EIN: 422885524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591335 FILM NUMBER: 261183159 BUSINESS ADDRESS: STREET 1: 670 N. COMMERCIAL STREET STREET 2: SUITE 403 CITY: MANCHESTER STATE: NH ZIP: 03101 BUSINESS PHONE: 603-518-8112 MAIL ADDRESS: STREET 1: 70 FEDERAL STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0002141066 AVSF - Alloy Therapeutics 2026, LLC 70 Federal St 6th Floor Boston MA MASSACHUSETTS 02110 603-518-8112 DELAWARE None None Limited Liability Company true 2026 Michael Collins 670 N. Commercial St Suite 403 Manchester NH NEW HAMPSHIRE 03101 Executive Officer CEO of Alumni Ventures LLC, the Issuers Sole Manager Pooled Investment Fund Venture Capital Fund false $1 - $1,000,000 06b 3C 3C.1 false 2026-07-02 false true true false 10000 None None None None n/a n/a n/a NH NEW HAMPSHIRE 03101 All States false Indefinite 25000 Indefinite false 1 0 0 0 false AVSF - Alloy Therapeutics 2026, LLC Hilary Ncala Hilary Ncala Sr VP, Alumni Funds of Issuers Sole Manager 2026-07-17